International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 24 | Views: 131 | Weekly Hits: ⮙1 | Monthly Hits: ⮙19

Case Studies | Pathology | India | Volume 13 Issue 10, October 2024 | Rating: 7.1 / 10


Histopathological Study of Ovarian Neoplasms in a Tertiary Health Care Centre

Dr. Balla Santhoshi | Dr. Manisha Mohapatra


Abstract: Introduction: Ovarian neoplasms comprise of a wide spectrum of benign and malignant tumors. Malignant ovarian tumors attribute to 3.0% of all cancers; incidence is 25.0% among female genital tract malignancies. World - wide ovarian cancer is fifth most prevalent cancer. Aim: To study the clinical features of patients with ovarian neoplasms and categorize histopathologically into benign, borderline, malignant tumors and study their histopathological pattern. Materials and Methods: This study was conducted during January 2022 to December 2023 (2 years) which included all histopathologically diagnosed cases of ovarian neoplasms. Results: The study comprised of 84 females, belonging to age range 11 - 70 years, mean age being 40.5 years. Majority, 30 (35.7%) belonged to 51 - 60years. Majority 47 (56%) were primary malignant tumors and 33 (39.2%) had benign lesions followed by borderline tumors. Right ovary is the commonest site for most lesions. Serous cystadenocarcinoma was the most common histopathological type seen in 30 (64%) cases followed by 8 (17%) cases of granulosa cell tumors. Conclusion: This study depicted the clinical profile and spectrum of histopathological pattern of ovarian neoplasms. Histopathological diagnosis is essential for accurate diagnosis of ovarian tumors which helps the clinicians to decide further therapeutic management.


Keywords: Ovarian neoplasms, Benign, Malignant, Surface epithelial tumors, Serous cystadenocarcinoma


Edition: Volume 13 Issue 10, October 2024,


Pages: 10 - 16





Rate this Article


Select Rating (Lowest: 1, Highest: 10)

5

Your Comments

Characters: 0

Your Full Name:


Your Valid Email Address:


Verification Code will appear in 2 Seconds ... Wait

Top